The Study to YD312 Tablet in Patients With Diabetic Macular Edema
Public ClinicalTrials.gov record NCT03635814. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multi-center, Randomized, Double-blind, Dose-finding, Phase 2a Clinical Trial to Evaluate the Effecacy and Safety of YD312 Tablet in Patients With Diabetic Macular Edema
Study identification
- NCT ID
- NCT03635814
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- YD Global Life Science Co., Ltd.
- Industry
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- YD312 150mg Drug
- YD312 350mg Drug
- YD312 50mg Drug
Drug
Eligibility (public fields only)
- Age range
- 19 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 18, 2017
- Primary completion
- Jul 26, 2018
- Completion
- Mar 19, 2020
- Last update posted
- Jan 8, 2020
2017 – 2020
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AXIS Clinical Trials | Los Angeles | California | 90036 | — |
| South Flolida Clinical Trials | Hialeah | Florida | 33106 | — |
| Florida Retina Consultants | Lakeland | Florida | 33805 | — |
| Retina Associates | Chicago | Illinois | 60126 | — |
| Elman Retina Group | Baltimore | Maryland | 21237 | — |
| Cumberland Valley Retina Consultants | Hagerstown | Maryland | 21740 | — |
| Impact Clinical Trials LV | Las Vegas | Nevada | 89106 | — |
| NY Clinical Trials | New York | New York | 10022 | — |
| Vitro-Retinal Consultants, Inc | Painesville | Ohio | 44077 | — |
| Phensylvania Retina Specialists | Camp Hill | Pennsylvania | 17011 | — |
| WR-Clinsearch, LLC | Chattanooga | Tennessee | 37421 | — |
| Clinical Trials of Texas, Inc | San Antonio | Texas | 78229 | — |
| Wagner Macula & Retina Center | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03635814, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 8, 2020 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03635814 live on ClinicalTrials.gov.